HomeNewsBusinessAnnouncementsLupin receives FDA approval for SUPRAX Capsules
Trending Topics
Sensex Live
Shadowfax IPO
Union Budget 2026
Infosys Q3 FY26 Results Review
Gold Rate Today

Lupin receives FDA approval for SUPRAX Capsules

Lupin receives FDA approval for SUPRAX Capsules

June 05, 2012 / 12:15 IST
Story continues below Advertisement
Remove Ad

Lupin Ltd has informed BSE regarding a Press Release dated June 05, 2012 titled "Lupin receives FDA approval for SUPRAX (Cefixime) Capsules, 400 mg; NDA Approval to add to growing SUPRAX Franchise"Source : BSE

Read all announcements in Lupin

first published: Jun 5, 2012 12:15 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Follow Us On: Facebook twitter instagram linkedin youtube
Trending Topics
Sensex Today RIL Q3 Results Live Mumbai BMC Election Results Maharashtra Election Results Infosys Share Price Pune Election Results Old Tax Regime Nobel Peace Prize medal Gold Price Amazon Great Republic Day Sale
News
Business Markets Stocks India News City News Economy Mutual Funds Personal Finance IPO News Startups
Markets
Home Currencies Commodities Pre-Market IPO Global Market Bonds
Personal Finance
Home Loans up to 50 Lakhs Credit Cards Lifetime Free Finance Tracker New Fixed Deposits Fixed Deposit Comparison Fixed Income
Mutual Funds
Home MC 30 Top Ranked Funds ETFs Mutual Fund Screener
Tools
Income Tax Calculator EMI Calculator Retirement Planning Gratuity Calculator Petrol Price in India Diesel Price in India IFSC Code
Community
Stock Markets
Network 18 Sites
News18 Firstpost CNBC TV18 News18 Hindi Cricketnext Overdrive
Quick Links
About Us Contact Us Advisory Alert Advertise with Us Disclaimer Privacy Policy Cookie Policy Terms & Conditions Financial Terms (Glossary) Sitemap Investors
Download MC Apps:

Copyright © Network18 Media & Investments Limited. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.